Mitchell Schain

903 total citations
7 papers, 353 citations indexed

About

Mitchell Schain is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mitchell Schain has authored 7 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Mitchell Schain's work include Retinal Diseases and Treatments (6 papers), Retinal Imaging and Analysis (4 papers) and Retinal Development and Disorders (2 papers). Mitchell Schain is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Retinal Imaging and Analysis (4 papers) and Retinal Development and Disorders (2 papers). Mitchell Schain collaborates with scholars based in United States. Mitchell Schain's co-authors include Ted S. Acott, Richard G. Weleber, Dennis W. Schultz, Peter J. Francis, Jacek Majewski, Jürg Ott, Tara C. Matise, Michael L. Klein, Albert O. Edwards and Michael L. Klein and has published in prestigious journals such as The American Journal of Human Genetics, Human Molecular Genetics and American Journal of Ophthalmology.

In The Last Decade

Mitchell Schain

7 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell Schain United States 5 298 211 140 39 26 7 353
Arif Samad Canada 11 308 1.0× 215 1.0× 134 1.0× 12 0.3× 16 0.6× 16 399
Minoru Obazawa Japan 9 390 1.3× 181 0.9× 228 1.6× 47 1.2× 13 0.5× 10 462
Rachel Liptak United States 5 216 0.7× 140 0.7× 153 1.1× 26 0.7× 48 1.8× 9 295
James A. Kimble United States 8 245 0.8× 111 0.5× 151 1.1× 37 0.9× 6 0.2× 11 323
Pancy Oi Sin Tam Hong Kong 9 264 0.9× 125 0.6× 161 1.1× 11 0.3× 50 1.9× 11 374
Rosario Fernández‐Godino United States 10 267 0.9× 111 0.5× 288 2.1× 92 2.4× 47 1.8× 21 443
Jeffrey Dunmire United States 9 255 0.9× 132 0.6× 154 1.1× 20 0.5× 38 1.5× 12 383
Chloë M. Stanton United Kingdom 10 158 0.5× 78 0.4× 257 1.8× 59 1.5× 19 0.7× 13 389
Stephen J. Ryan United States 12 296 1.0× 233 1.1× 162 1.2× 17 0.4× 16 0.6× 18 385

Countries citing papers authored by Mitchell Schain

Since Specialization
Citations

This map shows the geographic impact of Mitchell Schain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Schain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Schain more than expected).

Fields of papers citing papers by Mitchell Schain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Schain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Schain. The network helps show where Mitchell Schain may publish in the future.

Co-authorship network of co-authors of Mitchell Schain

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Schain. A scholar is included among the top collaborators of Mitchell Schain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Schain. Mitchell Schain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Flaxel, Christina J., Mitchell Schain, Sara Hamon, & Peter J. Francis. (2011). PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF COMBINATION RANIBIZUMAB (LUCENTIS) AND BROMFENAC (XIBROM) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 32(3). 417–423. 34 indexed citations
2.
Barral, Sandra, Peter J. Francis, David Schultz, et al.. (2007). Expanded genome scan in extended families with age-related macular degeneration. American Journal of Ophthalmology. 143(2). 376–376. 1 indexed citations
3.
Barral, Sandra, Peter J. Francis, Dennis W. Schultz, et al.. (2006). Expanded Genome Scan in Extended Families with Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 47(12). 5453–5453. 14 indexed citations
4.
Weleber, Richard G., Jacek Majewski, David Schultz, et al.. (2003). Age-related Macular Degeneration: A Genome-wide Scan in Extended Families. Investigative Ophthalmology & Visual Science. 44(13). 1503–1503. 2 indexed citations
5.
Schultz, David, et al.. (2003). Evidence that FIBL-6 is the ARMD1 Gene. Investigative Ophthalmology & Visual Science. 44(13). 2017–2017. 4 indexed citations
6.
Schultz, Dennis W., Michael L. Klein, Mitchell Schain, et al.. (2003). Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Human Molecular Genetics. 12(24). 3315–3323. 146 indexed citations
7.
Majewski, Jacek, Dennis W. Schultz, Richard G. Weleber, et al.. (2003). Age-Related Macular Degeneration—a Genome Scan in Extended Families. The American Journal of Human Genetics. 73(3). 540–550. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026